-

MedMen Promotes Tyson Rossi to Chief Strategy Officer

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the nation, today announced the appointment of Tyson Rossi to the role of Chief Strategy Officer.

Rossi has been a member of MedMen’s executive management team since 2019, most recently serving as Senior Vice President, Product and Revenue. He is a retail and cannabis industry veteran, with over 25 years of experience in global brand strategy and vertical cannabis operations, including over a decade of experience in the legal cannabis space. Rossi co-founded a number of cannabis ventures, including Arizona-based multistate craft edibles company Flourish Cannabis; Bōdee Holdings, Inc., a privately held cannabis company headquartered in Phoenix, Arizona; and Los Angeles-based Edible Solutions, a leading consulting agency in the cannabis industry.

“We’re thrilled to promote Tyson Rossi to the role of Chief Strategy Officer, responsible for driving MedMen’s company strategy and expansion efforts while overseeing all product-related activities of our business. During his time at MedMen, Tyson’s keen retail insights and deep understanding of both product and the global cannabis landscape have been invaluable to the success of our business and the continued evolution of the MedMen brand,” said Michael Serruya, Interim CEO, MedMen. “I have the utmost confidence in Tyson’s ability to lead strategy as MedMen advances into a new phase of growth and progress, prioritizing profitability, a diverse roster of best-in-class brands, and the continued refinement of the industry’s premier retail experience.”

ABOUT MEDMEN:

MedMen is North America’s leading cannabis retailer with flagship locations in Los Angeles, Las Vegas, Chicago, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLite, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pickup. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen and The MedMen Foundation at www.medmen.com

Contacts

MedMen Media Contact:
Lisa Weser
MedMen@Trailblaze.co

MedMen Investor Relations Contact:
Investors@MedMen.com

MedMen Enterprises Inc.

CNSX:MMEN

Release Versions

Contacts

MedMen Media Contact:
Lisa Weser
MedMen@Trailblaze.co

MedMen Investor Relations Contact:
Investors@MedMen.com

More News From MedMen Enterprises Inc.

MedMen Announces Management and Board Changes

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e...

MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis (“MINT Cannabis”). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion. “We are pleased to announce...

MedMen Provides Annual Filing Status Report

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO (“MCTO”) by its principal regulator, the Br...
Back to Newsroom